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Abstract The present study involved comparison of adhesion of
Helicobacter pylori KH202 to immobilized Leb-oligosaccharide
carried on different carriers, i.e. Leb-oligosaccharide conjugated
with polyacrylamide, bovine serum albumin, and dipalmitoyl-
phosphatidylethanolamine (Leb-PAA, Leb-BSA, and Leb-
DPPE). All of the Leb-oligosaccharide-carrying neoglycoconju-
gates served as ligands for H. pylori. However, H. pylori
required 10-fold and 100-fold quantities of Leb-antigen to
adhere to Leb-PAA and to Leb-DPPE in comparison to the
quantity of Leb-antigen needed to adhere to Leb-BSA,
respectively. H. pylori adhesion to Leb-PAA and Leb-DPPE
was clearly inhibited by Leb-oligosaccharide, but adhesion to
Leb-BSA was hardly inhibited by the oligosaccharide. There-
fore, the carbohydrate carrier affects the affinity of H. pylori
KH202 toward Leb-antigen, although the bacteria recognize
Leb-antigen regardless of the carbohydrate carrier. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Helicobacter pylori have been shown to be the primary
cause of active chronic gastritis, are associated with the devel-
opment of gastric and duodenal ulcers, and may be associated
with gastric cancer [1^5]. Recognition of cell surface carbohy-
drates plays an essential role for colonization and initiation of
infection of H. pylori. It has been suggested that several sialic
acid-containing oligosaccharides, sulfated glycans, and glyco-
sphingolipids served as possible receptor molecules for
H. pylori [6^12]. Recent reports suggested that H. pylori rec-
ognized the Leb-antigen (FucK1-2GalL1-3(FucK1-4)GlcNAcL-
R) expressed on the gastric mucosa, since neoglycoproteins or
neoglycolipids containing Leb-oligosaccharide and an anti-
body against Leb-antigen inhibited the bacterial adhesion to
gastric mucosa [13^15]. In addition, it has been shown that
H. pylori adhere to a glycoprotein or a glycolipid containing
Leb-oligosaccharide [14]. These facts strongly suggest that
H. pylori recognize only the Leb-antigen of these glycoconju-
gates without regard to the carbohydrate carrier. However,
the e¡ect of carbohydrate carrier of Leb-antigen in terms of
bacterial adhesion remains unclear.
To address the possible role of carbohydrate carriers in
bacterial adhesion to carbohydrates, the present study in-
volved analysis of the direct adhesion of H. pylori to three
types of neoglycoconjugates carrying Leb-oligosaccharide im-
mobilized on plates, i.e. Leb-oligosaccharide conjugated with
polyacrylamide (PAA), bovine serum albumin (BSA), and di-
palmitoylphosphatidylethanolamine (DPPE) (Leb-PAA, Leb-
BSA, and Leb-DPPE).
2. Materials and methods
2.1. Materials
Leb-hexasaccharide (FucK1-2GalL1-3(FucK1-4)GlcNAcL1-3GalL1-
4Glc), Leb-hexasaccharide conjugated with BSA (Leb-BSA), lacto-N-
fucopentaose I (FucK1-2GalL1-3GlcNAcL1-3GalL1-4Glc; H-type 1),
and lacto-N-fucopentaose I-BSA (H-type 1-BSA) were purchased
from Funakoshi (Tokyo, Japan). The average carbohydrate content
of Leb-BSA and H-type 1-BSA is about 8 mol per BSA. The Leb-
neoglycolipid (Leb-DPPE) constructed with DPPE and Leb-hexasac-
charide and H-type 1-neoglycolipid (H-type 1-DPPE) constructed
with DPPE and lacto-N-fucopentaose I were synthesized and puri¢ed
in our laboratory as described previously [16]. It should be noted that
the hemiacetal ring of glucose residue at the reducing end of the ol-
igosaccharide of each neoglycolipid was unclosed by reductive amina-
tion. Purity of the Leb-DPPE and H-type 1-DPPE was con¢rmed
using matrix-assisted laser desorption ionization time of £ight (MAL-
DI-TOF) mass spectrometry. The biotin-labelled PAAs conjugated
with Leb-tetrasaccharide (FucK1-2GalL1-3(FucK1-4)Glc) (Leb-PAA-
biotin) and those conjugated with other histo-blood group antigen
oligosaccharides [17] were from Seikagaku Kogyo Co. (Tokyo, Ja-
pan). Molecular weight of each oligosaccharide-PAA-biotin probe is
about 30 to 40 kDa and the carbohydrate content is 20 mol%. An
anti-Leb monoclonal antibody (IgG1) was obtained from Chemicon
International Inc. (Temecula, CA, USA).
2.2. Bacterial strain and growth condition
H. pylori strain KH202 obtained from the Central Research Labo-
ratories of Kaken Pharmaceutical Co. Ltd (Kyoto, Japan) was cul-
tured on brain-heart infusion agar with de¢brinated horse blood (7%
v/v) under a microaerophilic condition at 37‡C for 3 days [12]. Sub-
sequently, the bacteria were transferred to a liquid medium of brucella
broth (Difco, Detroit, MI, USA) containing 7% fetal calf serum under
microaerophilic condition at 37‡C for 24 h. A bacterial suspension
with an absorbance of about 0.5 at 540 nm was used for the experi-
ments.
2.3. Immobilization of oligosaccharides on solid phase
The Leb-DPPE was dissolved in methanol at a concentration of 0.1
mg/ml. The solution (50 Wl) was placed in wells of a 96-well microtiter
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plate and dried overnight at 37‡C; then, the wells were blocked over-
night with PBS containing 3% BSA at 4‡C. For immobilization of
Leb-BSA, the solution (50 Wg/ml) was placed in wells of a 96-well
microtiter plate, kept overnight at 4‡C, and the wells were extensively
washed with PBS. Then, wells were blocked overnight with PBS con-
taining 3% BSA at 4‡C. For immobilization of Leb-PAA-biotin, wells
of a 96-well plate were ¢rst coated with 50 Wl of streptavidin (50 Wg/
ml) overnight at 4‡C, washed with PBS extensively, and then 50 Wl of
the oligosaccharide-PAA-biotin probes (50 Wg/ml) were placed in
wells. After the wells had been incubated for 1 h, they were washed
and the excess of streptavidin coated on the wells was masked with 0.1
mg/ml of biotin at room temperature for 1 h, followed by blocking
with 3% BSA in PBS. As the control, wells coated with streptavidin
were used after masking with biotin. The amount of Leb-antigen
coated on the solid phase was determined with ELISA using anti-
Leb monoclonal antibody followed by peroxidase-conjugated anti-
mouse IgG antibody. The absorbance at 415 nm was determined by
means of a Model 450 Microplate Reader (Bio-Rad Laboratories,
Hercules, CA, USA). When 50 Wg/ml of these glycoconjugates were
added to wells and the solid phase was coated, the wells coated with
Leb-BSA, Leb-PAA, and Leb-DPPE exhibited the absorbance at 415
nm of 0.32, 1.65, and 2.5, respectively.
2.4. Direct adhesion experiment of H. pylori
Individual assays were performed in triplicate at least twice. The
suspension (100 Wl) of H. pylori in culture medium was added to the
wells of a 96-well plate coated with glycoconjugates, and the plate was
incubated under microaerobic conditions at 37‡C for 90 min. After
incubation, non-adherent bacteria were washed three times with PBS,
the wells were allowed to react with mouse anti-H. pylori antiserum
(1:5000 dilution) in PBS containing 1% BSA at 37‡C for 1 h, followed
by peroxidase-conjugated goat anti-mouse IgG antibody (1:1000 di-
lution) in PBS containing 1% BSA at 37‡C for 1 h. After the wells
were washed with PBS containing 0.05% Tween-20, the remaining
enzyme activity in the well was visualized by incubation with 0.1%
H2O2 and 2,2P-azino-di-[3-ethylbenzothianozoline-6-sulfonic acid]
(ABTS) at room temperature for 30 min. The absorbance at 415
nm was determined by means of a Model 450 Microplate Reader.
Speci¢c adhesion of H. pylori to immobilized glycoconjugates was
determined from the di¡erence in absorbance with respect to the
glycoconjugate-immobilized wells and non-coated wells (for Leb-
BSA and Leb-DPPE), or biotin-coated wells (for oligosaccharide-con-
jugated PAA).
2.5. Inhibition of bacterial adherence
For inhibition of H. pylori adhesion to immobilized neoglycocon-
jugates by soluble inhibitors, the inhibitor was added to the suspen-
sion of H. pylori at the indicated concentrations, and the bacteria were
incubated under microaerobic conditions at 37‡C for 60 min. Then
the suspension was added to the wells of a 96-well plate coated with
Leb-oligosaccharide-carrying glycoconjugates, and the plate was incu-
bated in a microaerobic atmosphere at 37‡C for 90 min.
3. Results
3.1. Adhesion of H. pylori to immobilized histo-blood group
antigen oligosaccharides
It has been shown that H. pylori adhere to some blood
group antigens such as Leb and H-type 1 antigens [13^15].
To investigate the speci¢city of recognition of histo-blood
group antigen oligosaccharides by H. pylori strain KH202,
oligosaccharides conjugated with biotin-labelled PAA were
immobilized on the solid phase that had been pre-coated
with streptavidin, and the direct adhesion of H. pylori to
the immobilized oligosaccharides was compared. As shown
in Fig. 1, H. pylori adhered to only the Leb-PAA-immobilized
plate. In contrast, PAA derivatives of other histo-blood group
antigens did not serve as ligands for H. pylori. Therefore,
H. pylori strain KH202 appeared to speci¢cally recognize
Leb-antigen among the histo-blood group antigen oligosac-
charides.
3.2. Adhesion of H. pylori to di¡erent types of Leb-carrying
neoglycoconjugates
To investigate whether H. pylori strain KH202 recognizes
only the carbohydrate portion of Leb-carrying glycoconju-
gates regardless of the carbohydrate carrier, several synthetic
neoglycoconjugates carrying Leb-oligosaccharides were added
to wells in the same amounts (20 Wg/ml) and coated, and then
H. pylori adhesion to the Leb-oligosaccharide-coated solid
phase was examined. All of the neoglycoconjugates carrying
Leb-oligosaccharides, i.e. Leb-PAA, Leb-BSA, and Leb-DPPE,
served as ligands for H. pylori (Fig. 2). In contrast, lacto-N-
fucopentaose I-BSA (H-type 1-BSA) and H-type 1-DPPE as
well as H-type 1-PAA did not serve as receptors for H. pylori
(Fig. 2). These results suggest that H. pylori strain KH202
speci¢cally recognizes Leb-oligosaccharide, regardless of the
carbohydrate carrier.
Next, the relationship between H. pylori binding to the
immobilized Leb-oligosaccharide-carrying synthesized glyco-
conjugates and quantities of Leb-antigen immobilized in the
wells was examined. The quantity of Leb-antigens immobi-
lized on the plates was determined from the reactivity to the
anti-Leb monoclonal antibody. As shown in Fig. 3, the adhe-
sion of H. pylori to the immobilized Leb-carrying synthesized
glycoconjugates increased with respect to the increased quan-
tity of Leb-antigen on the plate. However, the quantity of Leb-
antigen required for the adhesion di¡ered among the Leb-
BSA, Leb-PAA, and Leb-DPPE. The adhesion of H. pylori
to immobilized Leb-BSA was clearly observed with absor-
bance of 0.02 at 415 nm as Leb-antigen quantity, and reached
a plateau at absorbance of 0.05. In contrast, the adhesion of
Fig. 1. Adhesion of H. pylori to immobilized oligosaccharide-PAA.
The PAA conjugated with the following histo-blood group antigen
oligosaccharides and biotin (oligosaccharide-PAA-biotin) (50 Wg/ml)
was added to wells of a 96-well plate and coated, as described in
Section 2: blood group type A-trisaccharide (A-tri), blood group
type B-trisaccharide (B-tri), 3P-sulfo-Lea-tetrasaccharide (3P-0-sul-
Lea), sialyl-Lea, blood group H-type 1-trisaccharide (H-type 1),
blood group H-type 2-trisaccharide (H-type 2), Ley-tetrasaccharide,
Lex-trisaccharide, Leb-tetrasaccharide, and Lea-trisaccharide. Wells
coated with streptavidin and biotin were used as non-coated wells.
The suspension (100 Wl) of H. pylori was then added to the wells of
a 96-well plate coated with glycoconjugates, and the plate was incu-
bated under microaerobic conditions at 37‡C for 90 min. The specif-
ic adhesion of H. pylori to immobilized glycoconjugates was ob-
tained from the di¡erence in absorbance with respect to the
glycoconjugate-immobilized wells and non-coated wells (A415 = 0.03).
Adhesion of H. pylori to sulfatide was used as a positive control.
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H. pylori to immobilized Leb-PAA was not observed with
absorbance of 0.2 at 415 nm with respect to the Leb-antigen
quantity, the point of the strongest adherence of H. pylori to
the Leb-BSA-coated plate. Past absorbance of 0.2 at 415 nm,
the adhesion of H. pylori to the Leb-PAA-coated plate in-
creased in tandem with the increased quantity of Leb-antigen,
and reached a plateau at the absorbance of 1.5. In addition,
the maximum binding of H. pylori to Leb-PAA was about
one-third of that to Leb-BSA (Fig. 3). A greater quantity of
Leb-antigen was required on the plate (beyond absorbance of
1.0 at 415 nm) for adhesion to the Leb-DPPE-coated plate
(Fig. 3). Therefore, the quantity of Leb-antigen in the solid
phase needed for H. pylori adhesion di¡ered among the car-
riers that bind Leb-antigen.
3.3. Inhibition of H. pylori adhesion to Leb-neoglycoconjugates
by Leb-oligosaccharide
To con¢rm that H. pylori preferentially recognized Leb-
antigen carried on BSA rather than on lipids or PAA, three
kinds of neoglycoconjugates were placed in the solid phase at
the concentration with the strongest adherence of H. pylori
(see Fig. 3), the solid phase was coated, and the adhesion of
H. pylori to Leb-carrying glycoconjugate-coated plates was
inhibited by the Leb-oligosaccharide (FucK1-2GalL1-
3(FucK1-4)GlcNAcL1-3GalL1-4Glc). As shown in Fig. 4, the
Fig. 2. Adhesion of H. pylori to di¡erent types of Leb-neoglycocon-
jugates. The synthetic neoglycoconjugates carrying Leb-oligosaccha-
ride (Leb-BSA, Leb-PAA, and Leb-DPPE, each 20 Wg/ml) were
added to wells of a 96-well plate and coated, as described in
Section 2.
Fig. 3. Adhesion of H. pylori to di¡erent amounts of neoglycocon-
jugates carrying Leb-antigen. 100 Wg/ml of Leb-BSA (b), Leb-PAA
(E), or Leb-DPPE (R) was two-fold serially diluted, and the neogly-
coconjugate carrying Leb-antigen (100 Wl) was added to wells of two
96-well plates at the di¡erent concentration and coated on wells as
described in Section 2. The immobilized Leb-antigen in wells was
determined from the reactivity of the wells of one plate against an
anti-Leb monoclonal antibody (indicated in abscissa), as described
in Section 2. Non-coated wells were used as the control for Leb-
BSA- or Leb-DPPE-coated wells (a), and streptavidin-biotin-coated
wells were used as the control for Leb-PAA-coated wells (O).
Fig. 4. Inhibition of H. pylori adhesion by Leb-oligosaccharide. 50
Wg/ml of Leb-BSA and Leb-PAA, and 100 Wg/ml of Leb-DPPE,
where adhesion of H. pylori to wells coated with Leb-BSA, Leb-
PAA, and Leb-DPPE was the strongest as shown in Fig. 3, were
coated on wells of a 96-well plate. A: Di¡erent concentrations (0^
50 Wg/ml) of Leb-oligosaccharide were added to the suspension of
H. pylori, and incubated at 37‡C for 60 min under microaerobic
conditions. (b) Leb-BSA-coated wells ; (E) Leb-PAA-coated wells;
(R) Leb-DPPE-coated wells. The ordinate represents the relative ad-
hesion with respect to the adhesion of H. pylori without the oligo-
saccharide. Adhesion to Leb-BSA, Leb-PAA, and Leb-DPPE with-
out the oligosaccharide was 1.17, 0.52, and 0.87, respectively, at
A415. B: Represents the inhibition of H. pylori adhesion to Leb-
BSA-coated wells by a high concentration of Leb-oligosaccharide (b)
or Leb-BSA (a).
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adhesion of H. pylori to the Leb-DPPE-coated plate was al-
most completely inhibited by Leb-oligosaccharide at a concen-
tration of 10 Wg/ml. The same concentration of Leb-oligosac-
charide (10 Wg/ml) inhibited about 50% of adhesion to the
Leb-PAA-coated plate. The inhibition of bacterial adhesion
to Leb-PAA- and Leb-DPPE-coated plates by the soluble ol-
igosaccharide appeared in a concentration-dependent manner.
On the other hand, the inhibition of adhesion to the Leb-BSA-
coated plate by the oligosaccharide was almost negligible even
when 50 Wg/ml of inhibitor was used (Fig. 4A). With much
higher concentrations of Leb-oligosaccharide, the adhesion of
H. pylori to Leb-BSA-coated plate was inhibited by Leb-oli-
gosaccharide in a concentration-dependent manner, but 2 mg/
ml of the oligosaccharide inhibited only 50% of the adhesion
(Fig. 4B). Leb-PAA (100 Wg/ml) inhibited the adhesion to Leb-
PAA and Leb-DPPE to a greater degree than Leb-oligosac-
charide but did not inhibit adhesion to Leb-BSA (Table 1). In
contrast, 100 Wg/ml of Leb-BSA inhibited H. pylori adhesion
to the Leb-BSA-coated plate by about 50% (Fig. 4B) and al-
most completely inhibited adhesion to the Leb-DPPE- or Leb-
PAA-coated plate (Table 1). The same concentration of
H-type 1-BSA or BSA did not inhibit H. pylori adhesion to
the Leb-BSA-coated plate as well as to the Leb-PAA- and Leb-
DPPE-coated plates (Table 1). The concentration of Leb-oli-
gosaccharide required for 50% inhibition of the bacterial ad-
hesion to Leb-DPPE-, Leb-PAA-, and Leb-BSA-coated plates
was about 2, 10, and 2000 Wg/ml, respectively. These results
indicate that H. pylori KH202 adheres to Leb-BSA with the
highest a⁄nity among the di¡erent types of Leb-carrying neo-
glycoconjugates. Therefore, a certain con¢guration of glyco-
conjugates may be required in addition to the speci¢c carbo-
hydrate structure when the carbohydrates serve as high
a⁄nity receptors for H. pylori.
4. Discussion
The studies of carbohydrate receptors for H. pylori have
thus far focused on the structure of carbohydrates, and sev-
eral candidate carbohydrates including Leb-antigen have been
demonstrated [6^15]. However, no research has explored the
role of carbohydrate carriers in bacterial adhesion. The
present study involved comparison of the direct adhesion of
H. pylori strain KH202 to solid phase-coated Leb-oligosaccha-
ride carried on di¡erent types of carriers, i.e. protein, lipid,
and PAA, in order to clarify the possible role of the carbohy-
drate carrier in the adhesion of H. pylori to carbohydrates.
With direct adhesion and inhibition studies, the results dem-
onstrate that the carbohydrate carrier signi¢cantly a¡ects the
a⁄nity of H. pylori adhesion to Leb-oligosaccharide, although
H. pylori recognize Leb-antigen regardless of the carbohydrate
carrier, as indicated previously [13^15].
Leb-PAA, Leb-BSA, and Leb-DPPE served as ligands for
H. pylori KH202, indicating that the FucK1-2GalL1-3(FucK1-
4)GlcNAcL-R structure (Leb-antigen) is recognized by this
strain regardless of the carbohydrate carriers. However, the
quantity of Leb-antigen required on the solid phase for adhe-
sion of H. pylori clearly di¡ers among the glycoconjugates
carrying Leb-oligosaccharide. When Leb-BSA was coated on
the solid phase, H. pylori KH202 adhered strongly to the solid
phase only with small quantities of Leb-antigen (Leb-antigen
quantity in the solid phase of A415 = 0.02 as determined by
anti-Leb monoclonal antibody and shown in Fig. 3). In con-
trast, these bacteria required 100 times the quantity of Leb-
antigen (A415 = 2.0) to adhere to the Leb-DPPE-coated plate
than they did to adhere to the Leb-BSA-coated plate. It
should be noted that the oligosaccharide portions of both
Leb-BSA and Leb-DPPE are the same Leb-hexasaccharide
(FucK1-2GalL1-3(FucK1-4)GlcNAcL1-3GalL1-4Glc),
although the hemiacetal ring of glucose residue at the reduc-
ing end of the oligosaccharide of Leb-DPPE was unclosed by
reductive amination, indicating that the di¡erence in the
quantity of Leb-antigen on the plate required for the adhesion
between these two Leb-glycoconjugates is primarily due to the
di¡erences in the carrier of the oligosaccharide (i.e. protein or
lipid). Similarly, the bacteria required 10 times the quantity of
Leb-antigen (A415 = 0.2) to adhere to the Leb-DPPE-coated
plate than they did to adhere to the Leb-BSA-coated plate.
The di¡erence in the binding a⁄nity of H. pylori to these
glycoconjugates was con¢rmed by the inhibition of H. pylori
adhesion by Leb-oligosaccharide. The concentration of Leb-
oligosaccharide required for 50% inhibition of the bacterial
adhesion to immobilized Leb-carrying neoglycoconjugates
ranked in the order from Leb-BSAFLeb-PAAsLeb-
DPPE. It is notably that the adhesion of H. pylori to Leb-
BSA-coated plates is hardly inhibited by Leb-oligosaccharide
or Leb-PAA, but clearly inhibited with Leb-BSA.
An established ¢nding is that the carbohydrate binding af-
¢nity of lectin is enhanced by multivalent carbohydrates [18].
The carbohydrate content of Leb-BSA is about 10 wt% and
that of Leb-PAA is about 65 wt%, indicating that the oligo-
saccharides are more multivalent in Leb-PAA than in Leb-
BSA. However, H. pylori adhered to Leb-BSA with higher
a⁄nity than Leb-PAA. Therefore, the high a⁄nity of H. py-
lori to Leb-BSA may not be simply explained by the multi-
valence of the carbohydrates. Further studies are required
regarding the relationship between the binding a⁄nity of
H. pylori to carbohydrates and the multivalence of the carbo-
hydrates.
We have recently shown that H. pylori have a stronger
recognition for glycosphingolipids with K-hydroxyl fatty acid
than those with non-hydroxyl fatty acid, suggesting that a
speci¢c con¢guration is required for the recognition of glyco-
sphingolipids by H. pylori [12]. As shown in the present study,
the carrier also signi¢cantly a¡ects adhesion of H. pylori to
Leb-antigen. Therefore, carbohydrate carriers as well as car-
bohydrate structures are important factors in understanding
the adhesion of H. pylori to carbohydrate receptors.
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Inhibition of H. pylori adhesion to Leb-oligosaccharide-coated plate
by neoglycoconjugates
Inhibitora Relative adhesion to immobilized
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aEach inhibitor was used at a concentration of 100 Wg/ml.
bAdhesion of H. pylori without an inhibitor was used as the con-
trol.
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